RxDoctor Payments Data

Kathryn Swanson

Nurse Practitioner · Southbridge, MANPI 1437216546

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.3% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,302 and has fallen 55.5% since, to $579 in 2025. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,546in general payments, 2019–2025

Across 179 payments — averaging $25.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$663
  • AbbVie$627
  • Johnson & Johnson$619
  • Regeneron Healthcare Solutions, Inc.$555
  • Lilly USA, LLC$550
  • LEO Pharma Inc.$284
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$4,28694%
  • Education$2606%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,546 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.

See all nurse practitioner providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$109,310
Medicare patients
472
Services billed
2,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab11$141,691
Dupixent PenDupilumab34$133,073
Halobetasol Propionate186$5,999
Fluocinonide92$5,176
Ketoconazole118$2,375
Triamcinolone Acetonide141$2,177
Minocycline Hcl51$1,836
Fluorouracil25$1,166
Clindamycin Phosphate34$1,109
Clobetasol Propionate22$923
Hydrocortisone99$568
Betamethasone Dipropionate11$403
Prednisone39$173
Mupirocin25$156

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Southbridge

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →